Ignite Creation Date:
2025-12-18 @ 8:21 AM
Ignite Modification Date:
2025-12-18 @ 8:21 AM
Study NCT ID:
NCT00470015
Status:
None
Last Update Posted:
2019-02-19 00:00:00
First Post:
2007-05-03 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
ACTUAL
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-03 00:00:00
First Submit QC Date:
None
Study First Post Date:
2007-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-15 00:00:00
Last Update Post Date:
2019-02-19 00:00:00
Last Update Post Date Type:
ACTUAL